Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.03.2024 | Case report

Axitinib/sunitinib

Lack of efficacy and hypertension, fatigue and body aches

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Zhang H, et al. Sintilimab combined with axitinib in the treatment of advanced chromophobe renal cell carcinoma: a case report. Frontiers in Oncology 14: Jan 2024. Available from: URL: https://dx.doi.org/10.3389/fonc.2024.1325999 Zhang H, et al. Sintilimab combined with axitinib in the treatment of advanced chromophobe renal cell carcinoma: a case report. Frontiers in Oncology 14: Jan 2024. Available from: URL: https://dx.doi.org/10.3389/fonc.2024.1325999
Metadaten
Titel
Axitinib/sunitinib
Lack of efficacy and hypertension, fatigue and body aches
Publikationsdatum
01.03.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-54376-1

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Epcoritamab

Case report

Olanzapine